CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) is down 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is a fresh bearish analyst call from J.P. Morgan, which re-initiated coverage with an Underweight rating and a $92 price target. That note appears to have revived concerns that the stock’s premium valuation may be hard to sustain if volume momentum cools in 2027, especially with no new company announcement out today to offset the negative sentiment.

Details:

J.P. Morgan re-initiated coverage on September 4 with an Underweight rating and argued that earnings expectations and valuation could face pressure if future volume growth slows.

The same analyst note highlighted tougher 2027 comparisons and sugar-tax risk in Europe, giving investors a specific reason to trim exposure.

CCEP had already been facing valuation scrutiny after a prior August downgrade, which centered on limited upside following a strong year-to-date rally.

Recent company results were solid, with first-half 2026 comparable revenue up and volume growth still positive, so today’s pullback looks more tied to sentiment and multiple compression than to a new operational setback.

Sources:

CCEP Investor Relations, TipRanks, GuruFocus

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CCEP Hedge Fund Activity

We have seen 274 institutional investors add shares of $CCEP stock to their portfolio, and 326 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 9,362,150 shares (+61.3%) to their portfolio in Q2 2026, for an estimated $936,870,350
JPMORGAN CHASE & CO added 2,701,535 shares (+inf%) to their portfolio in Q2 2026, for an estimated $270,342,607
FMR LLC added 2,089,673 shares (+206.3%) to their portfolio in Q2 2026, for an estimated $209,113,577
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,895,501 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $189,682,785
JANE STREET GROUP, LLC removed 1,692,708 shares (-96.1%) from their portfolio in Q2 2026, for an estimated $169,389,289
LAZARD ASSET MANAGEMENT LLC removed 1,102,110 shares (-59.7%) from their portfolio in Q2 2026, for an estimated $110,288,147
FIDUCIARY MANAGEMENT INC /WI/ removed 802,103 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $80,266,447

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CCEP Congressional Stock Trading

Members of Congress have traded $CCEP stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CCEP stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CCEP Analyst Ratings

Wall Street analysts have issued reports on $CCEP in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 04/30/2026
UBS issued a "Buy" rating on 04/29/2026

To track analyst ratings and price targets for $CCEP, check out Quiver Quantitative's $CCEP forecast page.

$CCEP Price Targets

Multiple analysts have issued price targets for $CCEP recently. We have seen 3 analysts offer price targets for $CCEP in the last 6 months, with a median target of $109.0.

Here are some recent targets:

Chris Carey from Wells Fargo set a target price of $115.0 on 07/08/2026
Lauren Lieberman from Barclays set a target price of $108.0 on 04/30/2026
Sanjeet Auija from UBS set a target price of $109.0 on 04/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.